(1S,2R)-N-hydroxy-1-ethyl-2-[methyl((4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxamide

ID: ALA4100973

PubChem CID: 11856679

Max Phase: Preclinical

Molecular Formula: C26H31N3O5S

Molecular Weight: 497.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@]1(C(=O)NO)CCC[C@H]1N(C)S(=O)(=O)c1ccc(OCc2cc(C)nc3ccccc23)cc1

Standard InChI:  InChI=1S/C26H31N3O5S/c1-4-26(25(30)28-31)15-7-10-24(26)29(3)35(32,33)21-13-11-20(12-14-21)34-17-19-16-18(2)27-23-9-6-5-8-22(19)23/h5-6,8-9,11-14,16,24,31H,4,7,10,15,17H2,1-3H3,(H,28,30)/t24-,26+/m1/s1

Standard InChI Key:  HSFNYQQMBCDKTR-RSXGOPAZSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    8.5455   -9.8164    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9622  -10.5330    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.3745   -9.8139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8190   -9.6955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8179  -10.5229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5326  -10.9357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5308   -9.2828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2463   -9.6918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2470  -10.5186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9623  -10.9296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6772  -10.5149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6725   -9.6850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9567   -9.2777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1044   -9.2832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5345  -11.7606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8211  -12.1747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1057  -11.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1084  -10.9397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3938  -10.5290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6794  -10.9432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6839  -11.7724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2504  -10.9484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2535  -11.7734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5931  -12.2609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8509  -13.0444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6759  -13.0415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9278  -12.2559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1748  -11.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5850  -10.8256    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3498  -11.5438    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9352  -10.8306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7915  -12.4704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4006  -12.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2116  -11.8836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5343  -10.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 33 17  1  0
 20  2  1  0
  2 22  1  0
 23 22  1  6
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
 24 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 24 32  1  1
 21 33  2  0
 32 34  1  0
 22 35  1  0
M  END

Associated Targets(Human)

ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adam17 ADAM17 (101 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 497.62Molecular Weight (Monoisotopic): 497.1984AlogP: 4.20#Rotatable Bonds: 8
Polar Surface Area: 108.83Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.82CX Basic pKa: 5.02CX LogP: 3.81CX LogD: 3.79
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: -0.64

References

1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF..  (2017)  Identification of novel TACE inhibitors compatible with topical application.,  27  (8): [PMID:28274635] [10.1016/j.bmcl.2017.02.035]

Source